Rocuronium (ORG 9426) has been shown to have an onset of action more rapid than other nondepolarizing neuromuscular blocking agents and to provide intubating conditions similar to those of succinylcholine 60-90 s after administration. We compared the intubating conditions and hemodynamic changes after the administration of rocuronium 0.6 mg kg À1 and lidocaine 1.5 mg kg À1 with rocuronium alone and succinylcholine 60 and 90 s after administration.
# Acta Anaesthesiologica Scandinavica 47 (2003) S uccinylcholine, which has a rapid onset of action, is the muscle relaxant of choice for rapid sequence induction in patients with a full stomach. There are clinical situations, however, in which the use of succinylcholine is contraindicated. These include susceptibility to malignant hyperthermia, myotonia, plasma cholinesterase deficiency, neurological disorders and sepsis (1) . Rocuronium is a non-depolarizing neuromuscular blocking drug that provides rapid onset with an intermediate duration of action and is recommended as an alternative to succinylcholine in doses of 0.9-1.2 mg kg À1 (2-6). However, clinical duration of action with these doses are significantly longer than with succinylcholine (4) (5) (6) .
Drugs that suppress laryngeal reflexes such as sedative premedication, opioids or benzodiazepines may be used to facilitate endotracheal intubation. Lidocaine i.v. may further facilitate intubation by suppression of reflexes during tracheal intubation (7, 8) .
This study was designed to assess whether lidocaine i.v. with low-dose (0.6 mg kg
À1
) rocuronium can improve intubating conditions in rapid tracheal intubation and to establish how this combination compares with succinylcholine.
Methods
Afterobtaining institutional Ethic Committee approval, 125 consenting ASA class I or II adult patients undergoing elective surgery under general anesthesia were included in the study. Patients who were suspected to have difficulty in intubation were excluded. Patients were premedicated with atropine 0.5 mg and petidine 50 mg i.m. 1 h before induction of anesthesia. Routine monitoring consisted of electrocardiogram (ECG), automatic blood pressure monitoring and pulse oximetry.
followed by 3 min of preoxygenation. Alfentanil was administered to all patients for the purpose of sedation, not for its beneficial effects on endotracheal intubation. Anesthesia was induced in a 'rapidsequence' fashion with propofol 2 mg kg À1 followed by succinylcholine 1 mg kg À1 or rocuronium 0.6 mg kg À1 . Lidocaine was given as a bolus in groups RL 60 and RL 90 , over 5 s, just before propofol induction. The injection speed of propofol was identical in all subjects. The injection of propofol (2 mg kg
À1
) was controlled over 20 s. The infusion line was flushed for several seconds because of the physical incompatibility of the drugs. The muscle relaxant was administered to all groups 20 s after the bolus injection of propofol. It is a general tenet of anesthesia that a patient should not be paralyzed until control of the airway is assured. Therefore, during this 20-s period, ventilation of the patients was observed, and after adequate ventilation was maintained with a mask the muscle relaxant was administered. Then, the neuromuscular relaxant was administered over 5 s. Patients were randomly allocated into five groups using a computer-generated 
Intubation
We used plastic endotracheal tubes with an internal diameter of 8.5 cm (male patients) and 7.5 cm (female patients). Using a Macintosh (Heine, Germany) size 4 blade, the same fully trained anesthesist performed all intubations. Tracheal intubation was performed 60 s after administration of the muscle relaxant in groups Su, R 60 and RL 60 , and 90 s after administration of rocuronium in groups R 90 and RL 90 .
Sixty or 90 s after the end of the muscle relaxant injection, the intubating anesthesist was called to enter the study room and the intubating anesthesist was instructed by an assistant to start laryngoscopy. Intubating conditions were clinically assessed by the same experienced anesthetist who was also blinded to which group each patient was assigned and to the time of administration of the muscle relaxants. Intubating conditions were graded on a four-point scale as excellent, good, poor or inadequate according to the method described by Goldberg et al. (9) (Table 1) . The scale of Goldberg we used for global assessment of intubating conditions seemed more simple and practical. Excellent and good intubating scores are defined as 'clinically acceptable' and poor and inadequate intubating scores are rated as 'unacceptable'.
The tube was placed in the trachea as soon as possible. The cuff of the tube was inflated immediately after placement of the tube. Anesthesia maintenance was achieved with isoflurane (end-tidal concentration 1-1.5%) in 60% N 2 O and O 2 .
Heart rate and blood pressure were noted just before induction (baseline), before tracheal intubation and 1 min after tracheal intubation.
Hemodynamic data between groups were compared using one-way ANOVA. Comparison of demographic data and intubating conditions were analyzed with the Chi-square test. Group size (25 patients in each group) was selected by using proportions sample size estimates (power ¼ 80%, á ¼ 0.05) to detect the difference in intubation scores between the groups. Differences were considered significant at P<0.05. All values are given as mean (SD).
Results
One hundred and twenty-five patients were enrolled and all completed the study. There were no differences in the demographic characteristics between the two groups with respect to age, weight or ASA physical status (Table 2) .
Mean arterial blood pressure decreased in all groups after induction of anesthesia (P< 0.01) compared with baseline and increased significantly after Table 1 Grading of intubation conditions (6 tracheal intubation compared with the levels after induction of anesthesia (P< 0.01) ( Table 3 ). After tracheal intubation, heart rate increased only in groups R 60 and R 90 compared with levels before intubation (P< 0.05). Heart rate in groups S, RL 60 and RL 90 did not change after tracheal intubation (Table 4 ). All patients had good to excellent intubation scores, with two exceptions of poor scoring in groups R 60 and R 90 (Table 5 ). Intubation scores for groups Su, RL 60 , R 90 and RL 90 were found to be better than for group R 60 (P< 0.05). There was no significant difference in acceptable intubation scores between groups Su and RL 60 , RL 90 and R 90 .
No side-effects were observed related to lidocaine.
Discussion
Intubating conditions with succinylcholine were clinically acceptable (excellent and good intubating scores) in all patients, which is consistent with clinical experience. We have observed that groups in which rocuronium was used had also clinically acceptable intubating conditions. These results are similar to reports of other studies (10) (11) (12) (13) (14) (15) . However, as seen in Table 5 , 48% of patients in group R 60 had good intubating conditions with slight bucking or coughing. It may be speculated that even this slight reaction to intubation may result in regurgitation of gastric contents in a patient with a full stomach. Therefore, we suggest that rapid tracheal intubation (60 s) with rocuronium 0.6 mg kg À1 is not a safe alternative to succinylcholine. Addition of lidocaine to rocuronium significantly improved the intubating conditions, and the results were comparable to the succinylcholine group. It is observed that when the intubation time is extended to 90 s, intubation scores are significantly higher with rocuronium 0.6 mg kg
À1
. The dose-dependent decrease in onset time with rocuronium has been demonstrated before, and doses of 0.9-1.2 mg kg À1 have been found to be an acceptable alternative to succinylcholine for rapid tracheal intubation (2-6). However, the clinical duration of action with these doses was significantly longer than with succinylcholine (4, 5) and may present a clinical disadvantage, particularly in patients whose surgery is of short duration. Therefore we used a lower dose of rocuronium combined with lidocaine to see whether we could achieve acceptable intubating conditions. Administration of i.v. lidocaine has been shown to suppress both mechanically and chemically induced airway reflexes in a dose-dependent manner (8, (16) (17) (18) . The mechanisms by which i.v. lidocaine suppresses airway reflexes are unknown. However, rapid equilibration of local anesthetics between blood and brain suggest that a depressant effect on the central nervous system may contribute to this action (18) . Lidocaine produces a central sedative analgesic effect when introduced into the blood stream in appropriate doses. A peripheral tissue effect is also present, which, in part, accounts for the suppression of reflexes (8) . Suppression of pharyngeal and laryngeal reflexes permits the maintenance of airways in light planes of anesthesia. Lidocaine has been shown to reduce coughing and bucking when propofol and alfentanil are used for tracheal intubation without neuromuscular blockade (7, (9) (10) (11) (12) (13) (16) (17) (18) (19) . The degree of suppression of the cough reflex correlates with the plasma concentration (20) . Doses of 2 mg kg À1 given i.v. have been shown to cause systemic side-effects (7, 21) . Convulsive manifestations Table 4 Heart rate values are mean (SD). are not unlikely and are the result of an overdose.
Other potential side-effects such as decreased cardiac output, respiratory depression, allergy and idiosyncratic reactions may occur at larger doses (5 7 mg ml À1 of blood) (8) . One limitation of the lidocaine in the present study is the suppression of the airway reflexes with lidocaine before rapid sequence induction. This may be an unwanted effect especially in patients with a full stomach. However, it seems that the benefit/risk proportion is high and in advantage of using lidocaine, as it has various advantages. Besides, we chose to give 1.5 mg kg À1 of lidocaine, which is below the recommended maximal dose. Lidocaine i.v. is also effective in reducing the cardiovascular responses associated with intubation. It also prevents increases in intracranial pressure on intubation (8, 22) . Our results show that lidocaine administered at induction of anesthesia prevented the increase in heart rate after intubation, which can be a clinical advantage in patients with coronary artery disease. We also did not observe any side-effects related to lidocaine.
In this study we chose to measure hemodynamic changes and only qualitative clinical criteria for intubating conditions. As we have not monitored the onset and recovery times of rocuronium we can not comment on whether lidocaine shortens the onset time.
The results of this study appear not to be in agreement with some other studies (14, (23) (24) (25) . Dobson et al. (25) reported that clinically acceptable intubating conditions were achieved after administration of rocuronium 0.6 mg kg À1 to patients anesthetized with propofol 2.5 mg kg
. Although some of the early studies did not detect differences between rocuronium 0.6 mg kg À1 and succinylcholine 1.0 mg kg
, these studies were preliminary studies, not conducted during rapid-sequence induction of anesthesia, and performed in relatively small numbers of patients (2, 4, 15) . Huizinga et al. (15) concluded that 0.6 mg kg À1 of rocuronium may replace succinylcholine in procedures in which rapid sequence induction is required. Sparr et al. (14) also reported that 0.6 mg kg À1 rocuronium is a suitable alternative to succinylcholine for rapid tracheal intubation with thiopentone anesthesia in elective cases. However, Andrews et al. (6) observed that increasing the dose of rocuronium from 0.6 to 1.0 mg kg À1 improves intubating conditions and that 1.0 mg kg À1 of rocuronium is a more appropriate dose for rapid-sequence induction of anesthesia. Crul et al. (23) found that better intubation conditions were obtained at 60 s with 0.9 mg kg À1 than with 0.6 mg kg À1 of rocuronium. However, 0.9 mg kg
will produce longer duration, 50 min compared with approximately 30 min, following 0.6 mg kg
. Therefore, to avoid higher doses of rocuronium, opioids or other adjuvants such as lidocaine can be used as an integral part of a rapid-sequence induction to obtain intubation conditions similar to those of succinylcholine (5). Similar to this, our results indicate that rocuronium 0.6 mg kg À1 combined with lidocaine 1.5 mg kg À1 is a suitable alternative to succinylcholine 1 mg kg
. By this method, the longer duration of the high dose of rocuronium can be prevented to obtain clinically acceptable intubation conditions. In summary, we conclude that clinically acceptable intubating conditions were achieved with lidocaine 1.5 mg kg À1 and rocuronium 0.6 mg kg
, and that this combination may be a safe alternative in rapid tracheal intubation of patients when succinylcholine is contraindicated and especially when the surgery is of short duration. 
